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eSexual health interventions: promising, but more evidence 
needed
Chlamydia is a common sexually transmitted bacterial 
infection, which, when left untreated, can have long-
term adverse reproductive health effects.1 Despite the 
energetic National Chlamydia Screening Programme 
in the UK and increases in attendance at sexual health 
clinics, infection rates have changed little,2 and re-
infection rates are high—up to 30% among people 
tested a year after treatment.3 
Chlamydia infection is treatable, and approaches to 
effective control and treatment are well documented. 
Increasing the proportion of people with chlamydia 
who are treated, partner notification, and safe sexual 
practices, and decreasing time to treatment, are crucial 
to any programme aiming to reduce prevalence and 
transmission.4 Yet evidence suggests that interventions 
have so far had little success in reaching people at 
highest risk. Two-thirds of people testing positive 
for chlamydia in the third National Survey of Sexual 
Attitudes and Lifestyles had not had a test in the past 
year, and over three-quarters had not accessed sexual 
health services in the past year.5 Furthermore, although 
chlamydia disproportionately affects economically 
disadvantaged populations, this increased risk is not 
reflected in higher rates of attendance at sexual health 
services.5
Clearly, strategies for control and management of 
chlamydia need to leverage approaches that go beyond 
conventional service delivery. In The Lancet Public 
Health, Claudia Estcourt and colleagues report the 
findings of a feasibility study6 of a fully online chlamydia 
treatment and management system, an eSexual 
Health Clinic. Interventions based on information and 
communication technologies (ie, eHealth) have the 
potential to increase access to care, change behavioural 
risk factors, and increase self-management of disease 
with low costs. Indeed, interventions for which reliable 
evidence for efficacy is available, such as for smoking-
cessation support and diabetes management, are cost 
effective and feasible on a national scale.7–9
Internet and mobile phone delivery could be 
particularly appropriate for sexual health interventions, 
for which sensitivity, non-judgmental support, and 
privacy are required. Trials of eSexual health promotion 
interventions show benefits in terms of increased 
safe sex behaviours, testing for sexually transmitted 
infections, and service use, although some of these 
trials could have been prone to bias.10 The main model 
of online service provision for sexually transmitted 
infections has been internet-based testing, which 
involves ordering tests online with either signposting 
to the clinic for treatment or a telephone consultation 
followed by an e-prescription or postal treatment. The 
intervention reported by Estcourt and colleagues differs 
from existing eHealth interventions aimed at reducing 
prevalence and transmission of chlamydia in that all 
elements of the service were delivered electronically. 
Patients judged to be unsuitable for online care (for 
example, those with symptoms) were signposted to 
telephone support and clinic care. The intervention 
provides a web link to results, an online consultation, 
links to online health promotion, online partner 
notification, and an e-prescription for treatment. 
The work is innovative and has several strengths. 
At least among participants recruited from the UK’s 
National Chlamydia Screening Programme, preliminary 
and provisional data for key outcomes such as time to 
treatment, and completion of treatment seem similar 
to, or better than, outcomes achieved in face-to-face 
services. However, Estcourt and colleagues’ data suggest 
that, for those recruited from genitourinary medicine 
clinics, outcomes for the online chlamydia-management 
system could be poorer than those in genitourinary 
clinics that did not use the intervention, with a 
lower proportion of diagnosed patients completing 
treatment. Furthermore, few partners attended for 
treatment, and the impact on safe sex practices was not 
assessed. 
As the authors point out, their study was on a small 
scale, observational, and exploratory. The findings have 
generated ideas for improvement of their eSexual Health 
Clinic but have provided no robust evidence of outcome. 
A large-scale assessment of the final package of online 
chlamydia treatment and management services will 
be needed to reliably establish effectiveness and cost-
effectiveness, with attention to variation in use across 
different groups in terms of socioeconomic status, age, 
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gender, sexual orientation, and ethnicity. Careful study 
design will be needed to determine the appropriate 
mix of online and face-to-face service provision needed 
to maintain or improve the quality of, and access 
to, sexual health services across all patient groups. 
Because the intervention comprised several interacting 
components, individual actions, and organisational 
levels, any assessment of it will need to analyse both 
the individual and cumulative effects of components, 
and the likely interaction between them, on the primary 
and secondary outcomes (proportion treated, time to 
treatment, safety, and partner notification).
Should the results of such an assessment be 
favourable, substantial public health benefits could 
ensue. In the UK, where sexual health services are 
facing pressure to reduce costs, online sexual health 
services could help to provide high-quality and 
accessible health services at low costs for some groups 
of patients. Ultimately, in view of the potential value 
of the intervention, transferability would need to 
be investigated more widely. Several characterising 
features of the UK population and health system have 
facilitated development and deployment of the eSexual 
Health Clinic intervention: the National Health Service 
(NHS) is the only insurance and health-system provider, 
digital literacy and mobile phone use are high, electronic 
laboratory and pharmacy systems are electronically 
linked, and the Checkurself screening system (a free NHS 
home chlamydia test) is widely available. 
Outside the UK, and particularly in low-income and 
middle-income countries, the potential relevance of 
such an intervention could be affected by cost barriers 
to the client, including costs associated with phones 
and data subscription, poor access to the internet even 
in populations with high mobile phone ownership, 
and non-existent or poorly enforced laws around 
data privacy. Nevertheless, with necessary country 
adaptations, the digital interventions comprising the 
eSexual Health Clinic could offer substantial benefits 
to populations elsewhere. They have the potential to 
contribute to the achievement of the reproductive 
health objectives reflected in the UN Global Strategy for 
Women’s, Children’s, and Adolescents’ Health and to 
help to inform the upcoming WHO guidelines on digital 
health interventions for health-system strengthening 
within reproductive, maternal, newborn, child, and 
adolescent health, which is due in early 2018. 
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